ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Due to the inhibitory effect on BCR-ABL, it is usually used for treating chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia.